LULUN PROJECT II - Cohort Follow-up Study

Child stunting and micronutrient deficiencies are a major problem in developing countries, affecting millions of children.

Beginning at 6 months children need foods to complement nutrients received through breastfeeding; however, complementary feeding diets are well-documented to be inadequate in the developing world. Eggs, which are widely available and low-cost relative to other highly nutritious foods are underutilized and could potentially improve child growth and development. Prior to the Lulun Project RCT, no research had been conducted to evaluate their efficacy in improving micronutrient status. Lulun filled an important gap in the literature by examining, through a randomized controlled trial, the effect of egg consumption on biochemical markers of choline, vitamin B12, lipids, and amino acids in young children in a poor rural area of Ecuador. However, there is still scarce data on how early child complementary feeding interventions, such as the Lulun egg intervention, might impact child growth long-term.

This study will be designed as a follow-up cohort study to the Lulun Project RCT conducted in Cotopaxi Province from March-December 2015. The proposed follow-up study will investigate the potential long-term impacts of the egg intervention on child growth. Children and mother (caregiver) dyads with endline anthropometric measures from Lulun Project will be invited to participate in the follow-up study. Data will be collected on demographic, socioeconomic, and environmental information, morbidities, and child diet (including egg preparation and consumption), as well as child anthropometry (height, weight, head circumference). Additionally, the study will pilot test and compare radiographic measures of child bone maturity and organ size (kidney, liver, and spleen) using an app-based ultrasound. Investigators from Universidad de San Franscisco de Quito (USFQ), Washington University in St. Louis, and Mathile Institute will collaborate to conduct the study.

This project will also include a gender assessment component designed to ascertain how gender norms may affect prospects for successful scale up of smallholder poultry production. To this end, qualitative data will be collected from a small sample of participating mothers (caregivers) and key community stakeholders, in the form of in-depth interviews and/or focus groups.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

All mother (caregiver)-child dyads from the Lulun RCT will be contacted by mobile phone and invited to participate. A community meeting will first be held including community leaders and Lulun Project participants to present findings and explain the new follow-up study, Lulun Project II. This will give mothers (caregivers) the opportunity over at least a one week period to decide whether or not to participate and to discuss with family and friends. A field study team consisting of two individuals who participated in first trial and two students from Washington University will then contact mothers or caregivers and asked to come to various community sites used in the Lulun Project. Using processes and protocols from the original trial, mothers (caregivers) will first go through the informed consent and enrollment processes.

Eligibility criteria will include: 1) participant in the Lulun Project I; and 2) child healthy, without fever or severely malnourished. Mothers or primary caregivers of children will be given a written informed consent statement in Spanish to read and sign, indicating their consent and consent on behalf of their child. If the mothers/primary caregiver is less than 18 years of age, informed consent process will be sought from their parents or guardians. Participants with limited literacy will be offered the option to have the statement read to them. Caregivers will be invited to ask any questions about the nature of the study during this time.

For the gender analysis component of the study, a small number (10-20) of prospective mother (caregiver) participants, their partners, and key stakeholders will be contacted by phone by the Field Manager who will explain the nature and (qualitative) method of this part of the study. They will be invited to participate. Consent process for mothers, partners, and community stakeholders will occur after they agree to participate and just prior to interview or focus group.

Study Type

Observational

Enrollment (Actual)

270

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pichincha
      • Quito, Pichincha, Ecuador, 170901
        • Universidad San Francisco de Quito

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 years to 3 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Lulun Project II is a longitudinal follow-up study of the Lulun Project, which was conducted in Cotopaxi Province, Ecuador.

Description

Inclusion Criteria:

  • Participant in the Lulun Project I
  • Child healthy, without fever or severely malnourished

Exclusion Criteria:

  • Child not previously in the Lulun Project I
  • Child has fever or is severely malnourished

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Control Group
Intervention Group
Children previously in the intervention group received one egg per day for 6 months beginning when the child was between 6-9 months of age.
One egg per day for 6 months

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Height for Age Z-Score
Time Frame: One time point
One time point

Secondary Outcome Measures

Outcome Measure
Time Frame
Bone Age Z Score
Time Frame: One time point
One time point
Weight for Age Z Score
Time Frame: One time point
One time point
Weight for Height Z Score
Time Frame: One time point
One time point
BMI Z-Score
Time Frame: One time point
One time point
Head Circumference for Age Z-Score
Time Frame: One time point
One time point

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2017

Primary Completion (Actual)

August 31, 2017

Study Completion (Actual)

August 31, 2017

Study Registration Dates

First Submitted

April 1, 2019

First Submitted That Met QC Criteria

April 1, 2019

First Posted (Actual)

April 3, 2019

Study Record Updates

Last Update Posted (Actual)

April 3, 2019

Last Update Submitted That Met QC Criteria

April 1, 2019

Last Verified

April 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 201704100

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stunting

Clinical Trials on Egg

3
Subscribe